NORWOOD IMMUNOLOGY LTD has a total of 33 patent applications. Its first patent ever was published in 2000. It filed its patents most often in Australia, EPO (European Patent Office) and New Zealand. Its main competitors in its focus markets pharmaceuticals, environmental technology and biotechnology are URIGEN PHARMACEUTICALS INC, TWI BIOTECHNOLOGY INC and EIGENBRODT ERICH.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 10 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | New Zealand | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | South Africa | 3 | |
#6 | Canada | 2 | |
#7 | China | 2 | |
#8 | Republic of Korea | 2 | |
#9 | EAPO (Eurasian Patent Organization) | 1 | |
#10 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Boyd Richard | 24 |
#2 | Goldberg Gabrielle Lianne | 12 |
#3 | Chidgey Ann Patricia | 12 |
#4 | Sutherland Jayne Suzanne | 11 |
#5 | Boyd Richard Lennox | 4 |
#6 | Richard Boyd | 3 |
#7 | Suzanne Sutherland Jayne | 2 |
#8 | Patricia Chidgey Ann | 2 |
#9 | Lianne Goldberg Gabrielle | 1 |
#10 | Suzanne Goldberg Gabrielle Lia | 1 |
Publication | Filing date | Title |
---|---|---|
AU2007202610A1 | Normalization of defective T cell responsiveness through manipulation of thymic regeneration | |
AU2007202613A1 | Diagnostic indicator of thymic function | |
AU2007202609A1 | Stimulation of thymus for vaccination development | |
CN1809379A | Disease prevention and vaccination prior to thymic reactivations | |
ZA200509363B | Tolerance to graft prior to thymic regeneration | |
ZA200509362B | Disease prevention and vaccination prior to thymic reactivations | |
EP1620545A2 | Disease prevention and vaccination following thymic reactivation | |
US2008279812A1 | Disease Prevention and Vaccination Prior to Thymic Reactivation | |
ZA200303684B | Stimulation of thymus for vaccination development | |
AU2001295270C1 | Treatment of T cell disorders | |
AU2002225245B2 | Improvement of graft acceptance through manipulation of thymic regeneration | |
AU2002216320B2 | Hematopoietic stem cell gene therapy | |
AU2002216323B2 | Disease prevention by reactivation of the thymus |